Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Genoa Pharmaceuticals
701 Pike Street, Ste. 1500
Seattle, WA 98101
Phone: 619-992-6488
https://www.genoapharma.com/

Genoa Pharmaceuticals is a biopharmaceutical company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe pulmonary diseases. Genoa's lead program (Aerodone; inhaled pirfenidone) is on track to enter clinical development by year's end. Aerodone for the treatment of IPF has been granted orphan-drug designation by the US FDA.

Key Contact
Name
A. Bruce Montgomery
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
05/15/17 $62,000,000 Series A Edmond de Rothschild Investment Partners
F-Prime Capital Partners
Novo A/S
RiverVest Venture Partners
TPG Biotech
undisclosed